Insider Trading July 8, 2026 04:36 PM

Core Scientific Legal Officer Executes Pre-Arranged Stock Sale Amid Strategic Shifts

Todd DuChene divests $226,254 in shares under Rule 10b5-1 plan as the company navigates valuation debates and leadership expansion in the digital infrastructure sector.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
CORZ

Todd M. DuChene, serving as the Chief Legal and Administrative Officer for Core Scientific, Inc. (NASDAQ:CORZ), executed a sale of 10,000 shares of the company’s common stock on July 6, 2026. The transaction, valued at $226,254, was conducted at prices ranging from $22.24 to $23.15 per share, resulting in a weighted average sale price of $22.6254. This sale was facilitated through a Rule 10b5-1 trading plan established by DuChene on December 5, 2025. Following this transaction, DuChene retains direct ownership of 2,023,426 shares. The insider activity occurs against a backdrop of mixed market performance for Core Scientific, which has recorded a 54% return over the past year but has experienced a 9% decline in the past week. Analyst sentiment remains divided, with some firms highlighting the company's expansion into power capacity and its role in converting Bitcoin to high-performance computing, while others maintain a cautious stance due to perceived overvaluation relative to fair value estimates.

Core Scientific Legal Officer Executes Pre-Arranged Stock Sale Amid Strategic Shifts
CORZ
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Todd DuChene sold 10,000 shares of Core Scientific stock on July 6, 2026, under a pre-arranged Rule 10b5-1 trading plan established in December 2025.
  • Core Scientific is expanding its operational capacity with a new 430-megawatt power site in Hunt County, Texas, and has appointed Steve Smith, CEO of Zayo Group, to its board of directors.
  • Analyst sentiment on Core Scientific is divided, with BTIG and Lucid Capital Markets assigning Buy ratings while Freedom Broker initiated coverage with a Hold rating, citing valuation concerns.

Todd M. DuChene, who serves as the Chief Legal and Administrative Officer at Core Scientific, Inc. (NASDAQ:CORZ), executed a sale of 10,000 shares of the company’s common stock on July 6, 2026. The total value of the transaction amounted to $226,254.

The shares were sold at prices ranging from $22.24 to $23.15 per share, with a weighted average sale price of $22.6254. This transaction was carried out pursuant to a Rule 10b5-1 trading plan, which Mr. DuChene adopted on December 5, 2025.

The insider sale comes as Core Scientific stock has delivered a 54% return over the past year, though shares have declined 9% in the past week. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value estimate, placing it among highly valued equities. Investors can access comprehensive analysis through the company’s Pro Research Report, one of 1,400+ available for US stocks.

Following this sale, Mr. DuChene directly holds 2,023,426 shares of Core Scientific common stock.

In other recent news, Core Scientific has been the subject of multiple analyst reviews and corporate developments. BTIG raised its price target for Core Scientific to $33, maintaining a Buy rating, following the company’s expansion of power capacity with a new 430-megawatt site in Hunt County, Texas. Meanwhile, Lucid Capital Markets initiated coverage with a Buy rating and a price target of $40, noting Core Scientific’s role as a pioneer in converting Bitcoin to high-performance computing. In contrast, Freedom Broker started its coverage with a Hold rating and a price target of $33, reflecting a more cautious outlook.

Core Scientific has made significant changes to its board of directors. Steve Smith, CEO of Zayo Group, has been appointed to the board, bringing over 35 years of experience in digital infrastructure and technology sectors. During its 2026 Annual Meeting of Stockholders, Core Scientific elected five new board members to serve until the 2027 meeting. These developments indicate strategic moves by the company to strengthen its leadership and operational capacity.

Risks

  • Core Scientific stock is currently trading at a premium relative to its Fair Value estimate, suggesting potential overvaluation risks for investors.
  • The recent 9% decline in Core Scientific's stock price over the past week indicates short-term volatility that could impact investor confidence.
  • The company's strategic expansion into high-performance computing and power capacity involves significant capital deployment, which may introduce execution and financial risks in the digital infrastructure sector.

More from Insider Trading

Sezzle CFO Executes Pre-Arranged Sale Amid Stock Surge Jul 8, 2026 Symbotic Director Todd Krasnow Executes Stock Sales Amid Volatile Trading Period Jul 8, 2026 Stitch Fix CFO David Aufderhaar Executes $257,432 Share Disposition Under Pre-Arranged Plan Jul 8, 2026 Stitch Fix CPTO Bacos Executes $265K Share Sale Under Pre-Arranged Plan Jul 8, 2026 Indie Semiconductor COO Michael Wittmann Executes $29,213 Stock Sale Under Pre-Arranged Trading Plan Jul 8, 2026